Urges U.S. Department of Health and Human Services and federal Centers for Medicare and Medicaid Services to reconsider implementation of new rules concerning organ procurement organizations.
Impact
The Senate articulates that the proposed rules could lead to detrimental effects such as reduced organ procurement and transplantation rates, particularly affecting patients on national waiting lists. It highlights the current system's success and expresses worry that increased competition among OPOs will detract from their core missions, resulting in higher uncertainty within service areas. Additionally, there are concerns that this could disproportionately impact racial and ethnic minorities who already face disparities in accessing organ transplants.
Summary
Senate Resolution 54 urges the U.S. Department of Health and Human Services and the federal Centers for Medicare and Medicaid Services to reconsider the implementation of new rules that affect organ procurement organizations (OPOs). These new rules were adopted in December 2020 and are designed to revise the outcome measure requirements for OPOs, aiming to enhance donation rates and introduce competitive bidding for designated service areas they serve. The resolution expresses significant concerns surrounding the potential disruption these rules may cause to the organ transplantation system in New Jersey and nationwide.
Contention
During discussions, legislators pointed out a lack of empirical evidence supporting the effectiveness of competitive bidding and decertification processes proposed under the new CMS rules. Instead of fostering improvements, it is argued that these changes risk further complicating and undermining the effectiveness of the existing organ procurement network. Advocates emphasize the necessity for reconsideration to prevent future disparities, especially in light of already established inequities in healthcare access.
Carry Over
Urges U.S. Department of Health and Human Services and federal Centers for Medicare and Medicaid Services to reconsider implementation of new rules concerning organ procurement organizations.